Skip to content

Developing core outcome sets for clinical trials: issues to consider

Paula Ruth Williamson, Douglas G. Altman, Jane M. Blazeby, Mike J Clarke, Declan Devane, Elizabeth Gargon, Peter Tugwell

Trials · 2012 · 1,689 citationsOpen access

No retraction on record in OpenAlex.Check Crossref now

Cite this paper

Williamson, P. R., Altman, D. G., Blazeby, J. M., Clarke, M. J., Devane, D., Gargon, E., & Tugwell, P. (2012). Developing core outcome sets for clinical trials: issues to consider. Trials, 13(1), 132. https://doi.org/10.1186/1745-6215-13-132

In text: (Williamson et al., 2012)

Ask a question about this research

One question, free, no account. Anchorcite finds the papers, checks each against Crossref and links every sentence of the answer to the passage it comes from.

Abstract

The selection of appropriate outcomes or domains is crucial when designing clinical trials in order to compare directly the effects of different interventions in ways that minimize bias. If the findings are to influence policy and practice then the chosen outcomes need to be relevant and important to key stakeholders including patients and the public, health care professionals and others making decisions about health care. There is a growing recognition that insufficient attention has been paid to the outcomes measured in clinical trials. These issues could be addressed through the development and use of an agreed standardized collection of outcomes, known as a core outcome set, which should be measured and reported, as a minimum, in all trials for a specific clinical area. Accumulating work in this area has identified the need for general guidance on the development of core outcome sets. Key issues to consider in the development of a core outcome set include its scope, the stakeholder groups to involve, choice of consensus method and the achievement of a consensus.

  1. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews2021
  2. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation2018
  3. Classification of Surgical Complications2004
  4. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement2015
  5. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies2007

Metadata from OpenAlex (CC0). Citations are generated from the published record.